Study of NIB101 in Participants With Advanced Solid Tumors

NCT05192174 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped due to the reconsideration of development strategy

Conditions

Interventions

Sponsor

Noile-Immune Biotech, Inc